Clinical Trial Update: Dapagliflozin Efficacy and Action in NASH [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating dapagliflozin for efficacy and action in nonalcoholic steatohepatitis (NASH) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Nonalcoholic Steatohepatitis | Phase 3 | Status: COMPLETED